tirzepatide naion risk linked to lower for death, adverse CV and kidney outcomes vs. GLP-1s No Causal Link Discernable for

Fever, tachycardia, and hypertension may be observed during the recovery period and could raise suspicion for conditions such as malignant hyperthermia, serotonin syndrome, neuroleptic malignant syndrome, or 3,4-methylenedioxymethamphetamine (MDMA) overdose

Start todayMore Info Potential Weight Loss* Administration methods** Capsules Dose frequency*** Daily Potential side effects Possible side effects may include nausea, insomnia, dry mouth, constipation, and headache

Understanding proper peptide safety protocols becomes especially important with compounded medications

Researchers studying the role of dual incretin signaling may prefer tirzepatide, which provides a direct way to study GLP-1/GIP interaction effects